OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Persistent IDH mutations are not associated with increased relapse or death in patients with IDH-mutated acute myeloid leukemia undergoing allogeneic hematopoietic cell transplant with post-transplant cyclophosphamide
Niveditha Ravindra, Laura W. Dillon, Gege Gui, et al.
Bone Marrow Transplantation (2024) Vol. 59, Iss. 3, pp. 428-430
Closed Access | Times Cited: 6
Niveditha Ravindra, Laura W. Dillon, Gege Gui, et al.
Bone Marrow Transplantation (2024) Vol. 59, Iss. 3, pp. 428-430
Closed Access | Times Cited: 6
Showing 6 citing articles:
Therapeutic targeting of chromatin alterations in leukemia and solid tumors
Florian Perner, Tobias Berg, Daniel Sasca, et al.
International Journal of Cancer (2025)
Open Access
Florian Perner, Tobias Berg, Daniel Sasca, et al.
International Journal of Cancer (2025)
Open Access
Cladribine, idarubicin, and cytarabine (CLIA) for patients with relapsed and/or refractory acute myeloid leukemia: A single‐center, single‐arm, phase 2 trial
Hannah Goulart, Hagop M. Kantarjian, Gautam Borthakur, et al.
Cancer (2025) Vol. 131, Iss. 8
Closed Access
Hannah Goulart, Hagop M. Kantarjian, Gautam Borthakur, et al.
Cancer (2025) Vol. 131, Iss. 8
Closed Access
Measurable residual mutated IDH2 before allogeneic transplant for acute myeloid leukemia
Gege Gui, Niveditha Ravindra, Pranay S. Hegde, et al.
Bone Marrow Transplantation (2024)
Open Access | Times Cited: 3
Gege Gui, Niveditha Ravindra, Pranay S. Hegde, et al.
Bone Marrow Transplantation (2024)
Open Access | Times Cited: 3
Pre-emptive therapeutic decisions based on measurable residual disease status in acute myeloid leukemia: ready for prime time?
Firas El Chaer, Anthony J. Perissinotti, Sanam Loghavi, et al.
Leukemia (2024)
Closed Access | Times Cited: 3
Firas El Chaer, Anthony J. Perissinotti, Sanam Loghavi, et al.
Leukemia (2024)
Closed Access | Times Cited: 3
Measurable residual mutated IDH1 before allogeneic transplant for acute myeloid leukemia
Gege Gui, Niveditha Ravindra, Pranay S. Hegde, et al.
Bone Marrow Transplantation (2024)
Open Access | Times Cited: 2
Gege Gui, Niveditha Ravindra, Pranay S. Hegde, et al.
Bone Marrow Transplantation (2024)
Open Access | Times Cited: 2
The Validation of Digital PCR-Based Minimal Residual Disease Detection for the Common Mutations in IDH1 and IDH2 Genes in Patients with Acute Myeloid Leukemia
Jing Di, Tao Sheng, Rajeev Aurora, et al.
Journal of Molecular Diagnostics (2024)
Closed Access | Times Cited: 1
Jing Di, Tao Sheng, Rajeev Aurora, et al.
Journal of Molecular Diagnostics (2024)
Closed Access | Times Cited: 1
How complete must an AML remission be?
Christopher S. Hourigan
Blood (2024) Vol. 144, Iss. 2, pp. 131-132
Closed Access
Christopher S. Hourigan
Blood (2024) Vol. 144, Iss. 2, pp. 131-132
Closed Access
